Home » Prescription Drugs 7 » Femodene Generic Gestodene
FEMODENE 28: The memo-pack holds 21 white tablets diameter 5.7 mm containing 0.075 mg gestodene and 0.030 mg ethinylestradiol and in addition 7 larger white non-hormonal tablets diameter 6.8 mm.Indications:Oral contraceptionDosage and Administration:Combined oral contraceptives such as FEMODENE 28 when taken correctly have a failure rate of approximately 1% per year. The failure rate may increase when pills are missed or taken incorrectly.How to Take FEMODENE 28:Tablets must be taken in the order directed on the package every day at about the same time with some water as needed. Tablet-taking is continuous. One tablet is to be taken daily for 28 consecutive days. Each subsequent pack is started the day after the last tablet of the previous pack following the directional arrows. Withdrawal bleeding usually occurs while taking the 7 non-hormonal tablets. This usually starts on day 2 - 3 after starting the non-hormonal tablets and may not have finished before the next pack is started.How to Start FEMODENE 28:START WITH THE FIRST TABLET FROM THE GREEN SECTION MARKED WITH THAT DAY OF THE WEEK in accordance with one of the following:No preceding hormonal contraceptive use (in the past month) Tablet taking has to start on day 1 of the woman's natural cycle (i.e. the first day of her menstrual bleeding). Starting on days 2 - 3 is allowed but during the first cycle an additional barrier contraceptive method is recommended for the first 7 days of tablet taking.Changing from another combined oral contraceptive (COC) vaginal ring or transdermal patch The woman should start with FEMODENE 28 preferably on the day after the last hormonal tablet of her previous COC but at the latest on the day following the usual tablet-free or non-hormonal tablet interval of her previous COC.In case a vaginal ring or transdermal patch has been used the woman should start using FEMODENE 28 preferably on the day of removal but at the latest when the next application would have been due.Changing from a progestogen-only method (minipill injection implant) or progestogen-releasing intrauterine system (IUS) The woman may switch any day from the minipill from an implant or IUS on the day of its removal or from an injectable when the next injection would be due. In all of these cases the woman should be advised to additionally use a barrier contraceptive method for the first 7 days of tablet taking.Following first-trimester abortion The woman may start immediately. When doing so she need not take additional contraceptive measures.Following delivery or second-trimester abortion The woman should be advised to start at day 21 to 28 after delivery or second-trimester abortion. When starting later than this the woman should be advised to additionally use a barrier contraceptive method for the first 7 days of tablet taking. However if intercourse has already occurred pregnancy should be excluded before starting FEMODENE 28 or the woman has to wait for her first menstrual period.Management of Missed TabletsErrors in taking the non-hormonal tablets contained in FEMODENE 28 can be ignored. However they should be discarded to avoid unintentionally prolonging the placebo tablet phase. The following advice only refers to missed non-hormonal tablets:If the user is less than 12 hours late in taking any hormonal tablet contraceptive protection is not reduced. The woman should take the tablet as soon as she remembers and should take subsequent tablets at the usual time.If she is more than 12 hours late in taking any hormonal tablet contraceptive protection may be reduced.There is a particularly high risk of pregnancy if tablets are missed just before or immediately after taking the non-hormonal tablets. If tablets are missed in the first week of taking hormonal tablets following the non-hormonal tablets and intercourse took place in the preceding 7 days the possibility of pregnancy should be considered.The management of missed tablets can be guided by the following two basic rules:Tablet taking must never be discontinued for longer than 7 days. Seven days of uninterrupted tablet taking are required to attain adequate suppression of the hypothalamic-pituitary-ovarian axis. These rules form the basis of the instructions to patients provided in the package insert.
Buy Femodene Generic Gestodene and other Prescription Drugs 7 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Femodene Generic Gestodene:
Product Type: Prescription Drugs 7
Femodene ( Generic Gestodene/Ethinylestradiol )
Femodene (Generic Gestodene/Ethinylestradiol)
Generic Gestodene/Ethinylestradiol
0.075/0.030mg 84(3 x 28) Tablets 168(6 x 28) Tablets
Generic Gestodene/Ethinylestradiol Femodene

View more
Prescription Drugs 7
Previous Product Next Product
You do not need a prescription to buy our products as we work under the laws of the country we ship from. We do recommend you check with your local customs to see if it is okay to import these products.
Errors and Omissions. We are not responsible for any typographical errors or inaccuracies set forth in this website. The information, prices, and discounts set forth herein are subject to change without notice.
Product Fulfilment : The pharmacy / Fulfilment Centre cannot be held liable for the accuracy of the diagnosis, treatment or medication prescribed or the correct use of products supplied. It lies on the purchaser to use any products supplied under the guidance of a physician.
Product Quality. The Pharmacy / Fulfilment Centre is responsible for ensuring that the correct product, in the correct amount and the correct strength is supplied to the correct patient. Product liability lies solely with the manufacturer.
World Drug News. Government funding crisis in Swaziland disrupts supply of HIV/AIDS supplies. "An acute government funding crisis in Swaziland, Africa's last absolute monarchy, is disrupting supplies of HIV/AIDS drugs and hampering the fight against the virus in the country with the world's highest infection rate, Medecins Sans Frontieres (MSF) said Friday," Reuters reports. "Stocks of testing kits and related chemicals were 'almost dry,' making it next-to-impossible to chart the progress of the 70,000 patients on therapy or more than 130,000 other people carrying the virus, the aid agency said," according to Reuters.
"With 26 percent of its adult population, or more than 200,000 people infected, Swaziland ranks as the most AIDS-affected country," Reuters writes (Cropley, (9/9). In related news, a new report from Swaziland's government "has found that more than half of [30,000 Swazis, mostly women, working] in Swaziland's garment industry are living with HIV, and officials are realizing that the once-hailed promise of manufacturing employment has become a financial and medical nightmare for tens of thousands of Swazi women," PlusNews reports (8/11).
This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.
Glez Glucotrol
Gliben Daonil
Gliclazide Glyade
Glimax Amaryl
Glimy Amaryl
GLINATE Starlix
Glinil M Glucovance
GlucoBalance
Glucobay Precose
Glucophage Fortamet
Glucophage (Metformin)
Glucotrol (Glipizide SR)
Glucotrol XL Generic Glipizide
Glucovance Generic Glyburide
GLUMET Glucophage
Glynase Glucotrol
Glynase XL Glucotrol XL
Gonaphene Clomid
GRANICIP KYTRIL
Graniset Kytril
Grief & Pining Formula
Grisactin (Griseofulvin)
GRISOVIN Fulvicin


|